(R)-1-(2-(TRIFLUOROMETHYL)PHENYL)ETHANAMINE, 95.0%, 5g

4-N-Boc-amino-piperidine-4-carboxylic acid methyl ester oxalate, 97.0%, 1g

METHYL 2-HYDROXY-4-(2,2,2-TRIFLUOROACETAMIDO)BENZOATE, 95.0%, 250mg

3,5-Dineopentyl-4,5,7a,8,9,10,11,11a,12,13,14,15-dodecahydro-3H-dinaphtho[2,1-d:1',2'-f][1,3,2]diazaphosphepine 4-oxide, 98%, 50mg

Tetradecamethylhexasiloxane, 95%, 100g

5-Ethynyl-2-deoxyuridine (EdU), min. 98%, 5 mg, plastic packaging.

2,2-Dimethylsuccinic anhydride, 98.0%, 10g

4-Imidazol-1-ylmethylphenylamine, 95.0%, 100mg

3-(4-Fluoro-phenyl)-5-methyl-4,5-dihydro-isoxazole-5-carboxylic acid, 95.0%, 1g

1-Acetyladamantane, 95.0%, 5g

tert-butyl 2-azaspiro[4.5]dec-8-ylcarbamate, 95.0%, 100mg

2-(1-Methyl-1H-indazol-6-yl)acetic acid, 98+%, 1g

2-Benzyl-4-bromoisoindoline, 95.0%, 1g